EDUCELL PODJETJE ZA CELICNO BIOLOGI JO DOO

Their core work

Educell is a Slovenian private-sector biotechnology company specializing in cell biology, with core expertise in mesenchymal stem cell research and RNA interference (RNAi) therapeutics. The company develops calcium phosphate-based delivery systems — specifically apatite-mediated electroporation — to achieve efficient intracellular delivery of therapeutic siRNA into stem cells. Their work sits at the intersection of biomaterials science and gene silencing technology, enabling precise modulation of stem cell behavior for therapeutic purposes. As a host organization for an MSCA Individual Fellowship, they also function as a research incubation site for advanced cell biology talent in Slovenia.

What they specialise in

How they've shifted over time

Educell's documented H2020 activity begins with a tightly focused cell biology project — APApore4RNA — anchored in siRNA delivery into mesenchymal stem cells using calcium phosphate chemistry. Their subsequent participation in FibreNet (2017–2022), a training network on bio-based fibres, marks a visible expansion toward broader biomaterials territory, though no detailed keywords were captured for this later phase. With only two projects on record, the trend is tentative: this may represent deliberate diversification toward biopolymers or simply a specialist technical contribution to a consortium outside their core domain.

Educell appears to be extending from precision cell-biology methods (siRNA, electroporation, mesenchymal stem cells) toward broader biomaterials collaboration — but the evidence base is thin and the direction should be verified directly with the organization before building partnership assumptions around it.

How they like to work

Educell has both led a project — coordinating an MSCA Individual Fellowship and hosting an incoming researcher — and joined as a partner in a larger MSCA Training Network (FibreNet, 14 consortium partners). As a small SME, their coordinator role demonstrates capacity to drive focused research initiatives independently, while their ITN participation shows willingness to contribute specialist knowledge within multi-partner structures. Their overall profile fits a specialist contributor model: selected for precise technical depth rather than organizational scale or infrastructure.

Educell has worked with 14 unique consortium partners across 8 countries — a modest but genuinely pan-European footprint for a two-project SME. The breadth reflects the MSCA training network model, where geographic spread is built into funding requirements rather than emerging organically from long-term partnership ties.

What sets them apart

Educell occupies an unusual niche as a Slovenian private-sector cell biology company — most RNAi and stem cell research in the region resides in universities or public institutes, not SMEs, making their industrial status distinctive in consortium composition. Their specific combination of calcium phosphate biomaterials and siRNA delivery into mesenchymal stem cells is technically narrow enough to be genuinely differentiated in partner searches across regenerative medicine and advanced gene therapy calls. For consortium coordinators, Educell offers SME eligibility criteria alongside deep cell-biology specialization — a pairing that improves funding competitiveness without sacrificing scientific credibility.

Highlights from their portfolio

• APApore4RNA
  Coordinated by Educell as MSCA Individual Fellowship host, this project defines their core scientific identity — apatite-mediated electroporation for siRNA delivery into umbilical cord mesenchymal stem cells — and confirms their capacity to lead EU-funded research independently.
• FibreNet
  This 2017–2022 MSCA Training Network on bio-based fibre products represents Educell's step beyond core cell biology, suggesting a cross-disciplinary biomaterials contribution or an emerging diversification strategy.